Chammas & Marcheteau advised Hoppen and its historical partners on the investment in its capital by Après-demain SA. Après-demain SA, the parent company of Debiopharm active...
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here